Citation 19760

EDWARDS,MC: TAYLOR,SE: WILLIAMSON,EM: EVANS,FJ:. (1983). NEW PHORBOL AND DEOXYPHORBOL ESTERS: ISOLATION AND RELATIVE POTENCIES IN INDUCING PLATELET AGGREGATION AND ERYTHEMA OF SKIN.. 53(3)

Citation Details

Title	NEW PHORBOL AND DEOXYPHORBOL ESTERS: ISOLATION AND RELATIVE POTENCIES IN INDUCING PLATELET AGGREGATION AND ERYTHEMA OF SKIN.
Authors	EDWARDS,MC: TAYLOR,SE: WILLIAMSON,EM: EVANS,FJ:
Year	1983
Volume	53
Issue	3

Summary

Year: 1983

Journal: Unknown

Organisms and Their Experiments (3)

Sapium indicum (EUPHORBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBALDEHYDE-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
2	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBALDEHYDE-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
3	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBALDEHYDE-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
4	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBALDEHYDE-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
5	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
6	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
7	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
8	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
9	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-DEOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	None
10	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	ACTIVE
11	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	ACTIVE
12	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	ACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-DEOXY: 13-20-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
14	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-DEOXY: 13-20-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
15	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY: 13-20-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
16	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY: 13-20-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
17	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
18	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
19	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
20	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
21	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-ALPHA-DEOXY-13-20-DIACETOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
22	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY-13-20-DIACETOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
23	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-13-20-DIACETOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
24	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-13-20-DIACETOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
25	Not specified	ISOLATION OF NEW COMPOUND FOLLOWING SAPONIFICATIONMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	PHORBOL,4-ALPHA-DEOXY: 12-O-(2-METHYL-AMINO-BENZOYL):	None
26	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY: 12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
27	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY: 12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
28	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY: 12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
29	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBALDEHYDE-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
30	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBALDEHYDE-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
31	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBALDEHYDE-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
32	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBALDEHYDE-13-ACETATE,4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
33	Not specified	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-ALPHA-DEOXY-12-13-20-TRIACETOXY:	None
34	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY-12-13-20-TRIACETOXY:	INACTIVE
35	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-12-13-20-TRIACETOXY:	INACTIVE
36	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-12-13-20-TRIACETOXY:	INACTIVE
37	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,12-O-(2-METHYL-AMINO-BENZOYL):	None
38	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
39	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
40	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL ACETATE,TETRADECANOYL:	ACTIVE
2	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL ACETATE,TETRADECANOYL:	ACTIVE
3	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL ACETATE,TETRADECANOYL:	ACTIVE

Croton tiglium (EUPHORBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	PHORBOL	None
2	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL	INACTIVE
3	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL	INACTIVE
4	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL	INACTIVE
5	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
6	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
7	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
8	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
9	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	None
10	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	ACTIVE
11	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	ACTIVE
12	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-DEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):PHORBOL,4-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
14	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	ACTIVE
15	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
16	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,5-HYDROXY-4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
17	Not specified	ISOLATION OF NEW COMPOUND FOLLOWING SAPONIFICATIONMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	PHORBOL,5-HYDROXY-4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
18	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,5-HYDROXY-4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
19	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,5-HYDROXY-4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
20	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,5-HYDROXY-4-ALPHA-DEOXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,4-ALPHA-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
21	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-ALPHA-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
22	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
23	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
24	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-5-13-20-TRIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,4-ALPHA-DEOXY-5-HYDROXY-20-ACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
25	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-ALPHA-DEOXY-5-HYDROXY-20-ACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
26	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY-5-HYDROXY-20-ACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
27	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-5-HYDROXY-20-ACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
28	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY-5-HYDROXY-20-ACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,4-ALPHA-DEOXY: 5-HYDROXY: 12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
29	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-ALPHA-DEOXY: 5-HYDROXY: 12-O-(N-DECA-2-4-6-TRIENOYL):	None
30	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-ALPHA-DEOXY: 5-HYDROXY: 12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
31	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY: 5-HYDROXY: 12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
32	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-ALPHA-DEOXY: 5-HYDROXY: 12-O-(N-DECA-2-4-6-TRIENOYL):PHORBOL,4-DEOXY: 5-13-20-TRIACETOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
33	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-DEOXY: 5-13-20-TRIACETOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	None
34	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-DEOXY: 5-13-20-TRIACETOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
35	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY: 5-13-20-TRIACETOXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
36	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-DEOXY: 5-13-20-TRIACETOXY-12-O-(N-DECA-2-4-6-TRIENOYL):PHORBOL,13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
37	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
38	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
39	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
40	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
41	Not specified	TLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	None
42	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
43	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):	INACTIVE
44	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-DECA-2-4-6-TRIENOYL):PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-TETRADECANOYL):	INACTIVE
45	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-TETRADECANOYL):	None
46	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-TETRADECANOYL):	INACTIVE
47	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-TETRADECANOYL):	INACTIVE
48	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL-13-ACETATE,4-20-DIDEOXY-5-HYDROXY-12-O-(N-TETRADECANOYL):PHORBOL,4-20-DIDEOXY-5-13-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
49	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-20-DIDEOXY-5-13-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
50	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-20-DIDEOXY-5-13-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
51	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-20-DIDEOXY-5-13-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
52	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-20-DIDEOXY-5-13-DIACETOXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
53	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PHORBOL,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
54	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
55	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
56	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,4-20-DIDEOXY-5-HYDROXY-12-O-(2-METHYL-AMINO-BENZOYL):PHORBOL,5-HYDROXY-4-ALPHA-20-DIDEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
57	Not specified	ISOLATION OF NEW COMPOUND FOLLOWING SAPONIFICATIONMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	PHORBOL,5-HYDROXY-4-ALPHA-20-DIDEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	None
58	IRRITANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PHORBOL,5-HYDROXY-4-ALPHA-20-DIDEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
59	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,5-HYDROXY-4-ALPHA-20-DIDEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE
60	PLATELET AGGREGATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL,5-HYDROXY-4-ALPHA-20-DIDEOXY-12-O-(2-METHYL-AMINO-BENZOYL):	INACTIVE